Scott Powell | Executive Vice President of Investor Relations |
Cameron Reynolds | President and Chief Executive Officer |
Tom Butera | Chief Executive Officer, Volition Veterinary Diagnostics Development |
Terig Hughes | Chief Financial Officer |
Ross Osborn | Cantor Fitzgerald |
Good morning, ladies and gentlemen. Thank you for standing by. Welcome to VolitionRx Limited's First Quarter 2022 Earnings Conference Call.
During today's presentation, all parties will be in a listen-only mode.
Following the presentation, the conference call will be open for questions.